Holen Sie sich die Stockscreener-App
10.05
1.96%
-0.18
Schlusskurs vom Vortag:
$10.23
Offen:
$10.22
24-Stunden-Volumen:
589.99K
Relative Volume:
0.55
Marktkapitalisierung:
$1.06B
Einnahmen:
$247.00M
Nettoeinkommen (Verlust:
$-249.00M
KGV:
-3.2524
EPS:
-3.09
Netto-Cashflow:
$-267.00M
1W Leistung:
+8.32%
1M Leistung:
+26.16%
6M Leistung:
-23.38%
1J Leistung:
-36.56%
1-Tages-Spanne:
$9.93
$10.34
1-Wochen-Bereich:
$9.14
$10.34
52-Wochen-Spanne:
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
Firmenname
Arcus Biosciences Inc
Sektor
Branche
Telefon
(510) 694-6200
Adresse
3928 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie RCUS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
10.05 | 1.08B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.55 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.13 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.98 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.79 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.98 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-10-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-11-23 | Eingeleitet | Evercore ISI | Outperform |
| 2020-04-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-09-27 | Eingeleitet | Mizuho | Buy |
| 2019-05-24 | Fortgesetzt | Citigroup | Buy |
| 2018-10-09 | Eingeleitet | Wedbush | Outperform |
| 2018-04-09 | Eingeleitet | Citigroup | Buy |
| 2018-04-09 | Eingeleitet | Goldman | Neutral |
| 2018-04-09 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten
Is it the right time to buy Arcus Biosciences Inc. stockSuperior returns - jammulinksnews.com
Should I hold or sell Arcus Biosciences Inc. stock in 2025Explosive earning power - jammulinksnews.com
What are the latest earnings results for Arcus Biosciences Inc.Discover stocks with explosive growth potential - jammulinksnews.com
When is Arcus Biosciences Inc. stock expected to show significant growthMaximize gains with proven stock analysis - jammulinksnews.com
What is the dividend policy of Arcus Biosciences Inc. stockGet daily updates on the hottest stocks - jammulinksnews.com
What is Arcus Biosciences Inc. company’s growth strategyCapitalize on market momentum for big wins - jammulinksnews.com
Arcus Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayInvestor Favorite Picks - metal.it
How volatile is Arcus Biosciences Inc. stock compared to the marketMaximize portfolio growth with strategic plans - jammulinksnews.com
How Interest Rate Changes Impact Arcus Biosciences Inc. Stock PerformanceFree Stock Market Beginners Guide - Newser
Arcus Biosciences Inc. Stock Support and Resistance Levels You Should KnowFree Deep Market Trend Analysis - Newser
Bank of New York Mellon Corp Increases Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
New Product Launches: Will They Boost Arcus Biosciences Inc. Stock in 2025Safe and Smart Investment Picks - Newser
Is Arcus Biosciences Inc. stock a good hedge against inflationFree Stock Market Insider Analysis - Newser
What drives Arcus Biosciences Inc. stock priceExplosive earnings growth - PrintWeekIndia
Arcus Biosciences shares rise 3.65% intraday after granting new employee options and restricted stock units. - AInvest
Arcus Biosciences Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia
What analysts say about Arcus Biosciences Inc. stockRapidly growing investment returns - PrintWeekIndia
Is Arcus Biosciences Inc. a good long term investmentRecord-breaking gains - PrintWeekIndia
Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
Gilead and Arcus Biosciences’ Promising Lung Cancer Study: Market Implications - TipRanks
Arizona State Retirement System Purchases 5,010 Shares of Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study Update - TipRanks
Teacher Retirement System of Texas Has $143,000 Stake in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Principal Financial Group Inc. Boosts Holdings in Arcus Biosciences, Inc. (NYSE:RCUS) - Defense World
Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Trend Tracker for (RCUS) - news.stocktradersdaily.com
how arcus biosciences inc. stock performs during market volatilityTrending Stock Alert - Newser
How Arcus Biosciences Inc. stock performs during market volatilitySafe and Smart Investment Picks - Newser
What makes Arcus Biosciences Inc. stock price move sharplyFree Expert Investment Advice - Newser
Finanzdaten der Arcus Biosciences Inc-Aktie (RCUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):